Session Details
[1AT2-10]8. Biology of Diseases Ⅱ
Tue. Dec 1, 2026 11:15 AM - 12:45 PM JST
Tue. Dec 1, 2026 2:15 AM - 3:45 AM UTC
Tue. Dec 1, 2026 2:15 AM - 3:45 AM UTC
Room 10 (Conference Center 4F 413)
Chairs: Hideki Hara (Asahikawa Medical University), Michinaga Ogawa (Japan Institute for Health Security)
Presentation Time: 10 minutes (8 minutes for the presentation, 1 minute 30 seconds for discussion, and 30 seconds for transition)
[1AT2-10-01(1P-0579)]Restoration of Gap Junction Plaques as a Therapeutic Target for Age-Related Hearing Loss
○Takao Ukaji1,2, Kazusaku Kamiya2 (1. Sch. of Pha., Nihon University, 2. Dept. of Oto., Sch. of Med., Juntendo Univ.)
[1AT2-10-02(1P-0469)]Loss of leptin receptor suppresses gastric tumorigenesis by attenuating stromal reactions
○Kyoko Inagaki-Ohara1, Daisuke Motooka2, Takuya Kato1, Yasuhiko Minokoshi5, Akihiko Yoshimura4, Atsushi Enomoto3, Naoya Asai1 (1. Mol Pathol., Med, Fujita Health Univ., 2. Res. Inst. Microbial Dis., NGS Core Facil., The Univ. Osaka, 3. Grad. Sch. of Med., Nagoya Univ., 4. Res. Inst. for Biomed. Sci., Tokyo Univ. of Sci., , 5. Dep. Human Nutr., Sugiyama Jogakuen Univ.)
[1AT2-10-03(1P-0473)]Intracellular GGT1 as a Key Regulator of ER Stress and Proliferation in ANKL
○Akane Kanamori1,2,3, Yuji Miyatake2, Liyou Han6, Isshin Shiiba7, Toru Komatsu5, Ai Kotani2,4 (1. Tokyo Univ. Pharm. Life Sci., 2. RIMD, The University of Osaka, 3. Tokai Univ. Sch. Med., Mol. Life Sci., 4. Tokai Univ. Sch. Med., Immunol., 5. Pharm. Sci., Univ. of Tokyo, 6. ILAS, Kyoto Univ., 7. Pharm. Sci., Tohoku Univ.)
[1AT2-10-04(1P-0505)]AI-based TCR-pMHC binding prediction for interpreting antigen-specific T cell responses in autoimmune diseases
○Kazuki Nakanishi1,2, Hideyuki Shimizu1,2 (1. Grad. Sch. of Med. Dent. Sci., Inst. of Sci. Tokyo, 2. Dept. of AI Syst. Med., M&D Data Sci. Ctr., Inst. of Integrated Res., Inst. of Sci. Tokyo)
[1AT2-10-05(1P-0506)]ACC1-mediated de novo lipid biogenesis controls CD4+ T cell memory fate through the Blimp1 and IRF4 transcriptional network
○Keisuke Yamamoto1, Yusuke Endo1 (1. Kazusa DNA Research Institute)
[1AT2-10-06(1P-0345)]The NRF3–CTGF axis drives myCAF differentiation and neural invasion in the PDAC tumor microenvironment
○A K M Zakir Hossain1, Hirotomo Banno1, Riko Fukuda1, Keisuke Hisamatsu1, Takuto Michihara1, Taiga Asano1, Atsushi Hatanaka1, Atsushi Masamune3, Masayo Matsumoto3, Kazuhiko Igarashi3, Akira Kobayashi1,2 (1. Grad. Sch. Life and Med. Sci., Doshisha Univ. , 2. Fac. Life. and Med. Sci., Doshisha Univ., 3. Grad. Sch. Med.,Tohoku Univ.)
[1AT2-10-07(2P-0448)]Distinct Effects of Amino Acid Depletion- and Doxorubicin-Induced Senescence-like Cancer Cells on Tumor Growth and Tumor immunity
○Rei Abe1, Honoka Mita1, Iori Aketa1, Ayaka Ishibashi1, Togo Yamaguchi2, Tuyoshi Waku1,2, Akira Kobayashi1,2 (1. Grad. Sch. Life and Med. Sci., Doshisha Univ, 2. Fac. Life. And. Med. Sci., Doshisha Univ)
[1AT2-10-08(2P-0458)]IL-7R-FER signaling programs therapeutic T-cell brain trafficking for glioma immunotherapy
○Motochika Hamada1, Masahiro Yasunaga1 (1. Center for Research and Development of Advanced Medical Technology, National Cancer Center)
[1AT2-10-09(1P-0552)]Osteoblast-specific deletion of Ctdnep1 causes bone loss through impaired bone formation
○Manami Manami1, Waraku Shibata1, Takuto Konno1, Chisato Sampei1, Ryuichi Nishinakamura2, Tadayoshi Hayata1 (1. Dept. of Mol. Pharmacol., Grad. Sch. of Pharm. Sci., Tokyo Univ. of Sci., 2. Kid. Dev., IMEG, Kumamoto Univ.)
